SBRA – sabra health care reit, inc. (US:NASDAQ)

News

Sabra Healthcare REIT (SBRA) had its price target raised by Scotiabank from $20.00 to $21.00. They now have a "sector perform" rating on the stock.
Sabra Healthcare REIT (NASDAQ:SBRA) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Sabra Healthcare REIT (NASDAQ:SBRA) had its price target raised by analysts at Citizens Jmp from $22.00 to $23.00. They now have a "market outperform" rating on the stock.
Sabra Healthcare REIT (NASDAQ:SBRA) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Sabra Healthcare REIT (NASDAQ:SBRA) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com